NFE2L2 and non-small cell lung carcinoma: Thus, 61.7% of the specimens were Nrf2 positive, which was higher than the percentage of positive specimens reported in non-small cell lung carcinoma (26%) [21] or in gallbladder cancer (23%) [23].